Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver…
Read the full articleYou might also wanna read
Attovia Therapeutics files for Nasdaq IPO to fund immune-disease biologics
Tao Fu's San Carlos biotech is seeking an ATTO listing before disclosing price range, share count or valuation.
FMR LLC's Strategic Acquisition of Tenax Therapeutics Inc Shares
Related Stocks: TENX , AAPL , AMZN , GOOGL , MSFT , NVDA
Boxer Capital Management, LLC Acquires Significant Stake in Q32 Bio Inc
Related Stocks: QTTB , CELC , KOD , RVMD , KYMR , TNGX
Biotech NRx to sell new shares to fund growth and operations
#NRXP NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?
Targeted therapies meet AI-driven discovery as these biotech innovators reveal sharply contrasting financials, risk factors, and industry pa
SK Hynix ADRs Priced At 3% Premium As Wall Street Readies Wave Of Leveraged ETFs
SK Hynix ADRs Priced At 3% Premium As Wall Street Readies Wave Of Leveraged ETFs The next test of the AI trade arrives today, as South Korea
Comments
Sign in to join the conversation.
No comments yet. Be the first.